resM supports the same gut-hormone pathway through a clinically studied postbiotic blend.* Many customers pair it with their prescribed medication for complementary metabolic support - the postbiotic in resM demonstrated a 300% increase in GLP-1 hormone production in clinical studies.* Learn more about the science behind resM today
Sergey Terushkin, MD, FACS These educational resources can help patients better understand retatrutide research, tirzepatide treatment, medication concentration, and syringe-unit calculations
This phase marks the beginning of follicle regression and is triggered when growth signals diminish, precisely what happens when CXXC5 suppresses Wnt signaling
Cassia extract, as included in GLP-1 Plus, is presented in a concentrated form, aligning with the broader movement toward standardized ingredient sourcing in supplementation
What they found (summary): Development of Melanotan II as a cutaneous drug failed due to the combination of side effects Bifurcation into more selective derivatives was both scientifically and commercially successful PT-141 Bremelanotide (Vyleesi, 2019) Melanotan I Afamelanotide (Scenesse, 2014) Underground use of Melanotan II is safety-problematic Why it matters: This is the definitive historical review by the founders of the field
Trulicity is a synthetic GLP-1 receptor agonist (RA)
